The Safest Option in Trades!
If you’re new to trading, then you’ve probably heard the wrong thing about options—that they’re risky, unpredictable, or difficult.

And it couldn’t be more wrong! With the Hughes Optioneering Strategy, you’ll soon learn that the safest option for new accounts is options themselves!
Click here now!
Ted White, insider at Verrica Pharmaceuticals

Ted White Insider Information

Mr. White has served as Verrica Pharmaceuticals’ President and Chief Executive Officer since December 2017 and as a member of our Board of Directors since May 2018. Previously, he was President and General Manager at Almirall, a global pharmaceutical company, and the parent company of Aqua Pharmaceuticals, based in Barcelona, Spain, with a focus on Medical Dermatology. Prior to his time at Aqua Pharmaceuticals, Mr. White was at Novartis, where he served in a number of roles, including as Managing Director. He holds an MBA from St. Joseph’s University and a BA in General Arts from Villanova University.

What is Ted White's net worth?

The estimated net worth of Ted White is at least $117,864.00 as of July 5th, 2022. Mr. White owns 29,466 shares of Verrica Pharmaceuticals stock worth more than $117,864 as of August 15th. This net worth estimate does not reflect any other assets that Mr. White may own. Additionally, Mr. White receives an annual salary of $797,620.00 as CEO at Verrica Pharmaceuticals. Learn More about Ted White's net worth.

How old is Ted White?

Mr. White is currently 57 years old. There are 3 older executives and no younger executives at Verrica Pharmaceuticals. Learn More on Ted White's age.

What is Ted White's salary?

As the CEO of Verrica Pharmaceuticals Inc., Mr. White earned a total compensation package of $2,477,577.00 in 2021. Mr. White earned a salary of $550,000.00, options awards of $1,679,953.00, non-equity compensation of $206,250.00, and other compensation of $41,374.00. Learn More on Ted White's salary.

How do I contact Ted White?

The corporate mailing address for Mr. White and other Verrica Pharmaceuticals executives is 10 NORTH HIGH STREET SUITE 200, WEST CHESTER PA, 19380. Verrica Pharmaceuticals can also be reached via phone at (434) 453-3300 and via email at [email protected] Learn More on Ted White's contact information.

Has Ted White been buying or selling shares of Verrica Pharmaceuticals?

In the last ninety days, Ted White has bought $49,998.90 of Verrica Pharmaceuticals stock. Most recently, on Tuesday, July 5th, Ted White bought 23,809 shares of Verrica Pharmaceuticals stock. The stock was acquired at an average cost of $2.10 per share, with a total value of $49,998.90. Following the completion of the transaction, the chief executive officer now directly owns 29,466 shares of the company's stock, valued at $61,878.60. Learn More on Ted White's trading history.

Who are Verrica Pharmaceuticals' active insiders?

Verrica Pharmaceuticals' insider roster includes Matt Davidson (Major Shareholder), A. Davis (CFO), Christopher Hayes (Insider), Paul Manning (Director), and Ted White (CEO). Learn More on Verrica Pharmaceuticals' active insiders.

Are insiders buying or selling shares of Verrica Pharmaceuticals?

During the last year, Verrica Pharmaceuticals insiders bought shares 6 times. They purchased a total of 1,733,712 shares worth more than $3,871,214.25. The most recent insider tranaction occured on July, 11th when insider Christopher G Hayes bought 7,500 shares worth more than $25,500.00. Insiders at Verrica Pharmaceuticals own 43.5 % of the company. Learn More about insider trades at Verrica Pharmaceuticals.

Information on this page was last updated on 7/11/2022.

Ted White Insider Trading History at Verrica Pharmaceuticals

Transaction DateBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
7/5/2022Buy23,809$2.10$49,998.9029,466View SEC Filing Icon  
6/4/2021Buy4,000$9.95$39,800.0021,966View SEC Filing Icon  
8/13/2020Buy10,661$6.28$66,951.0817,966View SEC Filing Icon  
8/20/2018Buy300$16.36$4,908.00View SEC Filing Icon  
8/15/2018Buy2,505$15.69$39,303.45View SEC Filing Icon  
See Full Table

Ted White Buying and Selling Activity at Verrica Pharmaceuticals

This chart shows Ted White's buying and selling at Verrica Pharmaceuticals by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

Verrica Pharmaceuticals Company Overview

Verrica Pharmaceuticals logo
Verrica Pharmaceuticals Inc., a dermatology therapeutics company, develops and commercializes treatments for people with skin diseases in the United States. The company's lead product candidate includes VP-102 for the treatment of molluscum contagiosum; that has completed Phase II clinical trial for the treatment of external genital warts; and which is in Phase II clinical trial for treating common warts. It is also developing cantharidin-based product candidate, VP-103 for treating plantar warts. The company has a license and collaboration agreement with Torii Pharmaceutical Co., Ltd. for the development and commercialization of its product candidates for the treatment of molluscum contagiosum and common warts in Japan, including VP-102; and a license agreement with Lytix Biopharma AS to develop and commercialize LTX-315 for dermatological oncology indications. Verrica Pharmaceuticals Inc. was incorporated in 2013 and is headquartered in West Chester, Pennsylvania.
Read More

Today's Range

Now: $3.91
Low: $3.88
High: $4.13

50 Day Range

MA: $2.80
Low: $1.92
High: $4.04

2 Week Range

Now: $3.91
Low: $1.77
High: $14.79


108,985 shs

Average Volume

277,186 shs

Market Capitalization

$107.60 million

P/E Ratio


Dividend Yield



27 U.S. Cities Where Stocks Yield 26% a Year
What’s the highest-yielding stock you’ve ever owned? The dividends for these stocks have risen so fast over the years that they’re now yielding us an average of 26%!

When you start getting paid 26% on your money, your financial problems tend to pretty much evaporate.
Get in on the action here.